Searching for the ‘melano‐miRs’: miR‐214 drives melanoma metastasis
Open Access
- 18 May 2011
- journal article
- editorial
- Published by Springer Nature in The EMBO Journal
- Vol. 30 (10) , 1880-1881
Abstract
This article highlights the role of miR-214 in driving the metastatic phenotype in melanoma by targeting AP-2α and AP-2γ and thereby regulating extravasation, invasion and angiogenesis as reported by the Taverna laboratory.Keywords
This publication has 10 references indexed in Scilit:
- microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2CThe EMBO Journal, 2011
- Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotypeProceedings of the National Academy of Sciences, 2010
- MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant MelanomaJournal of Investigative Dermatology, 2010
- Melanoma MicroRNA Signature Predicts Post-Recurrence SurvivalClinical Cancer Research, 2010
- Role of miRNAs in the progression of malignant melanomaBritish Journal of Cancer, 2009
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorProceedings of the National Academy of Sciences, 2009
- Chromatin structure analyses identify miRNA promotersGenes & Development, 2008
- The Promyelocytic Leukemia Zinc Finger–MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic MechanismsCancer Research, 2008
- MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell LinesCancer Research, 2008
- Role of AP-2 in Tumor Growth and Metastasis of Human MelanomaCancer and Metastasis Reviews, 1999